10.1038/s41586-023-06026-3 - Targeting PD-L2–RGMb overcomes microb...

This document has been corrected

Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance

Published Online: 2023-05-03

Journal: Nature•Publisher: Springer Science and Business Media LLC

Authors: Amalia K. Luthens•Arlene H. Sharpe•Dennis L. Kasper•Elizabeth M. Park•Francesca S. Gazzaniga•Golnaz Morad•Gordon J. Freeman•Jacob Gillis•Jennifer A. Wargo•Joon Seok Park•Martin W. LaFleur•Meng Wu•Sarah B. Johnson•Stephanie S. Watowich•Wen Zheng•Yifan Zhou

This document has been corrected

Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance

Published Online: 2023-05-03

Journal: Nature

NOW

2023-06-01•Correction

Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance

10.1038/s41586-023-06237-8

* information provided by CrossRef

2023-06-01•Correction

10.1038/s41586-023-06237-8

* information provided by CrossRef

2023-05-03•Published

2023-06-01•Correction

Publisher Correction: Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance

10.1038/s41586-023-06237-8

* information provided by CrossRef

This document has been corrected

Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance

Published Online: 2023-05-03

Journal: Nature•Publisher: Springer Science and Business Media LLC